Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

2.

HIV signaling through CD4 and CCR5 activates Rho family GTPases that are required for optimal infection of primary CD4+ T cells.

Lucera MB, Fleissner Z, Tabler CO, Schlatzer DM, Troyer Z, Tilton JC.

Retrovirology. 2017 Jan 24;14(1):4. doi: 10.1186/s12977-017-0328-7.

3.

During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.

Kostadinova L, Shive CL, Judge C, Zebrowski E, Compan A, Rife K, Hirsch A, Falck-Ytter Y, Schlatzer DM, Li X, Chance MR, Rodriguez B, Popkin DL, Anthony DD.

J Infect Dis. 2016 Nov 1;214(9):1438-1448. Epub 2016 Aug 17.

4.

Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.

Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ.

Nature. 2015 Jun 11;522(7555):216-20. doi: 10.1038/nature14335. Epub 2015 Apr 20.

5.

Human β-defensin 3 induces STAT1 phosphorylation, tyrosine phosphatase activity, and cytokine synthesis in T cells.

Meisch JP, Vogel RM, Schlatzer DM, Li X, Chance MR, Levine AD.

J Leukoc Biol. 2013 Sep;94(3):459-71. doi: 10.1189/jlb.0612300. Epub 2013 Jun 26.

6.

Plasma proteome analysis reveals overlapping, yet distinct mechanisms of immune activation in chronic HCV and HIV infections.

Schlatzer DM, Sugalski JM, Chen Y, Barnholtz-Sloan J, Davitkov P, Hazlett FE, Funderburg N, Rodriguez B, Lederman MM, Sieg SF, Chance MR, Anthony DD.

J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):563-71. doi: 10.1097/QAI.0b013e3182909847.

7.

Human biomarker discovery and predictive models for disease progression for idiopathic pneumonia syndrome following allogeneic stem cell transplantation.

Schlatzer DM, Dazard JE, Ewing RM, Ilchenko S, Tomcheko SE, Eid S, Ho V, Yanik G, Chance MR, Cooke KR.

Mol Cell Proteomics. 2012 Jun;11(6):M111.015479. doi: 10.1074/mcp.M111.015479. Epub 2012 Feb 15.

8.

A quantitative proteomic approach for detecting protein profiles of activated human myeloid dendritic cells.

Schlatzer DM, Sugalski J, Dazard JE, Chance MR, Anthony DD.

J Immunol Methods. 2012 Jan 31;375(1-2):39-45. doi: 10.1016/j.jim.2011.09.004. Epub 2011 Sep 16.

9.

Urinary protein profiles in a rat model for diabetic complications.

Schlatzer DM, Dazard JE, Dharsee M, Ewing RM, Ilchenko S, Stewart I, Christ G, Chance MR.

Mol Cell Proteomics. 2009 Sep;8(9):2145-58. doi: 10.1074/mcp.M800558-MCP200. Epub 2009 Jun 4.

10.

A proteomic analysis of human cilia: identification of novel components.

Ostrowski LE, Blackburn K, Radde KM, Moyer MB, Schlatzer DM, Moseley A, Boucher RC.

Mol Cell Proteomics. 2002 Jun;1(6):451-65.

11.

The large subunit of the mammalian mitochondrial ribosome. Analysis of the complement of ribosomal proteins present.

Koc EC, Burkhart W, Blackburn K, Moyer MB, Schlatzer DM, Moseley A, Spremulli LL.

J Biol Chem. 2001 Nov 23;276(47):43958-69. Epub 2001 Sep 10.

Supplemental Content

Loading ...
Support Center